Suchergebnisse - (Subject:"Tocilizumab")

PubPharm (7)

1

Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis

enthalten in: Arthritis research & therapy | 2018

von Rivière, E. | Sellam, J. | Pascaud, J. | +3

2

Comparative effectiveness of abatacept versus tocilizumab in rheumatoid arthritis patients with prior TNFi exposure in the US Corrona registry

enthalten in: Arthritis research & therapy | 2016

von Harrold, L. | Reed, G. | Solomon, D. | +4

3

Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis : a retrospective observational study

enthalten in: Arthritis research & therapy | 2016

von Nakamura, S. | Suzuki, K. | Iijima, H. | +8

4

EuroQol-5 dimensions utility gain according to British and Swedish preference sets in rheumatoid arthritis treated with abatacept, rituximab, tocilizumab, or tumour necrosis factor inhibitors : a prospective cohort study from southern Sweden

enthalten in: Arthritis research & therapy | 2016

von Gülfe, A. | Wallman, J. | Kristensen, L.

5

Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study

enthalten in: Arthritis research & therapy | 2015

von Curtis, J. | Sarsour, K. | Napalkov, P. | +2

6

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

enthalten in: Arthritis research & therapy | 2013

von Crnkic Kapetanovic, M. | Saxne, T. | Jönsson, G. | +2

7

ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis : a systematic review of the literature

enthalten in: Arthritis research & therapy | 2009

von Alivernini, S. | Laria, A. | Gremese, E. | +2

1
[1]